ライフサイエンスコーパス: therapeutic goal

1 nflammation is an important preventative and therapeutic goal.

2 ence, making relapse prevention an essential therapeutic goal.

3 ment of neoangiogenesis remains a high-value therapeutic goal.

4 idely considered to be an alternative cancer therapeutic goal.

5 t ACE2 upregulation is viewed as a desirable therapeutic goal.

6 the face of aging is a critically important therapeutic goal.

7 ins of bacteria continues to be an important therapeutic goal.

8 nologic tolerance after transplantation is a therapeutic goal.

9 tion and myeloprotection remain an important therapeutic goal.

10 scle, and enhancing this response has been a therapeutic goal.

11 and preservation of cone function is a major therapeutic goal.

12 on in tumors is widely considered a valuable therapeutic goal.

13 hibition of pathological angiogenesis is the therapeutic goal.

14 inhibiting their actions represents a major therapeutic goal.

15 ease, and ischemia reduction is an important therapeutic goal.

16 the pathways regulating these responses is a therapeutic goal.

17 y optimized patients with HF is a worthwhile therapeutic goal.

18 Prevention of CAV progression is a primary therapeutic goal.

19 setting, where reducing patient anxiety is a therapeutic goal.

20 nhibition of A beta 42 production is a prime therapeutic goal.

21 hus, inhibition of A beta release is a prime therapeutic goal.

22 characteristics designed to achieve specific therapeutic goals.

23 ular delivery, a requirement for a number of therapeutic goals.

24 to fully harness the potential of hESCs for therapeutic goals.

25 ssible and of potential benefit for specific therapeutic goals.

26 e benefits of each, or have considered their therapeutic goals.

27 t groups in proportion of patients achieving therapeutic goals.

28 protein are becoming recognized as important therapeutic goals.

29 placement and photoreceptor rescue are major therapeutic goals.

30 gn of CpG-based products to achieve specific therapeutic goals.

31 and practice organization aimed at achieving therapeutic goals.

32 Reducing heteroplasmy is therefore a therapeutic goal and in vivo models in post-mitotic tiss

33 The therapeutic goal and mode changed in 22 (7%) and 21 case

34 s in conventional therapy, novel targets and therapeutic goals are the highlights of treatment for ul

35 ph-node (SLN) resection can achieve the same therapeutic goals as conventional ALND but with decrease

36 has been touted as a novel cancer-selective therapeutic goal based on the observation of high telome

37 If the therapeutic goals (cardiac index of > 4.5 L/min/m2, oxyg

38 One important therapeutic goal during CNS injury from trauma or demyel

39 inhibition by CSPG-rich scar is an important therapeutic goal for achieving functional recovery after

40 l of mast cell granule exocytosis is a major therapeutic goal for allergic and inflammatory diseases.

41 ng functional beta-cell mass is an important therapeutic goal for both type 1 and type 2 diabetes (1)

42 These complementary outcomes represent the therapeutic goal for future investigation in acute GVHD

43 of mutant beta-globin genes has long been a therapeutic goal for patients with beta-thalassemia or h

44 An important therapeutic goal for patients with type 2 diabetes is we

45 ng sPLA2-IIA mass is unlikely to be a useful therapeutic goal for preventing cardiovascular events.

46 Inhibiting Abeta generation is a prime therapeutic goal for preventing or treating Alzheimer di

47 g repair mechanism, may be a more attainable therapeutic goal for promoting functional repair after C

48 Inhibition of TF may represent a therapeutic goal for the prevention of thrombotic compli

49 The primary therapeutic goal for the treatment of diabetes is mainte

50 hypertrophy, whose inhibition is a long-term therapeutic goal for the treatment of the course of hear

51 A major therapeutic goal for type 1 diabetes (T1D) is to induce

52 t year and provides an expert opinion of the therapeutic goals for statin therapy.

53 pleted the scleral lens fitting process, and therapeutic goals (improved comfort, ocular surface prot

54 that proteinuria reduction is an appropriate therapeutic goal in chronic proteinuric kidney disease.

55 marker for long-term PFS and as a potential therapeutic goal in CLL.

56 ess AR activity as the single most important therapeutic goal in CRPC treatment.

57 Glucagon suppression should be a major therapeutic goal in diabetes.

58 of myelin is an important but still elusive therapeutic goal in many neurological disorders.

59 ropensity to recur and progress, the primary therapeutic goal in patients with high-risk NMIBC is the

60 Enhancing myelin repair remains an important therapeutic goal in primary demyelinating diseases of th

61 ort the role of inhibition of NF-kappaB as a therapeutic goal in RA.

62 s allograft tolerance, is a highly desirable therapeutic goal in solid organ transplantation.

63 Therefore, a therapeutic goal in SSD is pharmacologic reactivation of

64 immunologic effects that may be used with a therapeutic goal in the future.

65 osinophilic inflammation has been an elusive therapeutic goal in the management of asthma pathogenesi

66 A therapeutic goal in the treatment of certain CNS disease

67 hether progression-free survival is a worthy therapeutic goal in this disease setting.

68 of life raises issues about the appropriate therapeutic goal in treating heart failure.

69 ta) has emerged as one of the most important therapeutic goals in Alzheimer's disease.

70 nificant implications with regard to current therapeutic goals in asthma and allergy and suggest that

71 activity indices, definitions of remission, therapeutic goals (including mucosal healing) and outcom

72 ese factors will have limited effects if the therapeutic goal is a downmodulation of immune responses

73 es caused by mutations in a single gene, the therapeutic goal is tissue replacement using stem cells

74 The therapeutic goal is to normalise tissue exposure to cort

75 In each of these strategies, the therapeutic goal is to re-ignite T-cell immunity, in ord

76 Therapeutic goals may include replacing a defective gene

77 Eradication of HBsAg as a therapeutic goal might facilitate the induction of endog

78 ons of each model against the scientific and therapeutic goal of a prospective preclinical study.

79 ion of androgen receptor signaling remains a therapeutic goal of CRPC therapy.

80 While the therapeutic goal of generating Fc-fusion proteins has be

81 The therapeutic goal of our medicinal chemistry effort was t

82 eatment of intrabony defects is an important therapeutic goal of periodontal therapy.

83 llenges and opportunities in moving toward a therapeutic goal of regenerative cardiovascular medicine

84 t modulate atherosclerosis, and validate the therapeutic goal of skewing T responses to atheroscleros

85 which best reflects a failure to achieve the therapeutic goals of TAVR.

86 riteria, and provide management guidance and therapeutic goals on occurrence of these toxicities.

87 patient population, dosing regimen, type of therapeutic goals or end points (hemodynamic, or normal

88 The development of specific therapeutic goals provides a framework for assessments o

89 To effectively match cannabinoids with therapeutic goals, these compounds must be screened for

90 n of this condition may represent a possible therapeutic goal to interfere with the development of th

91 travenous vasodilator has been proposed as a therapeutic goal to reduce cardiac-wall stress and, pote

92 Control of viral replication is a major therapeutic goal to reduce morbidity and mortality from

93 Thus, B cells expressing CD40L can be a therapeutic goal to regulate inflammatory CD8 T cell res

94 n pressure may constitute the most important therapeutic goals to ameliorate secondary neurological d

95 tion of immune competence is one of the main therapeutic goals, we have evaluated reconstitution of t

96 The time at which all therapeutic goals were first achieved simultaneously or

97 The future therapeutic goal will be to treat patients earlier in th

98 tients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCOR

99 inal photoreceptor layer is lost, and so the therapeutic goal would be to restore vision at this stag